Bravecto Chews for Dogs: Complete Dosage, Safety & Side Effect Guide

If you've spent any time in a vet clinic lobby, you've probably seen the Bravecto display near the checkout counter. Since its FDA approval in 2014, Bravecto chews for dogs have become one of the most widely prescribed flea and tick preventives in the United States, with a single chew providing up to 12 weeks of protection. But like all prescription medications, it carries real risks that every dog owner should understand before filling that prescription.

This guide breaks down exactly how Bravecto chews work, what the clinical data says about side effects, how dosing works across weight classes, and when this medication might not be the right choice for your dog. All information references the FDA's Center for Veterinary Medicine labeling and the Merck Veterinary Manual.

What Are Bravecto Chews Used For in Dogs?

Bravecto chews are FDA-approved for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of four tick species in dogs aged 6 months and older weighing at least 4.4 pounds (2 kg):

• American dog tick (Dermacentor variabilis) — 12 weeks of protection
• Brown dog tick (Rhipicephalus sanguineus) — 12 weeks of protection
• Lone star tick (Amblyomma americanum) — 8 weeks of protection
• Black-legged tick / deer tick (Ixodes scapularis) — 12 weeks of protection

Bravecto is also FDA-approved as an aid in the treatment and control of tick infestations with the Gulf Coast tick (Amblyomma maculatum) for 12 weeks.

Common Off-Label Uses

Veterinarians sometimes prescribe fluralaner off-label for:

• Demodectic mange (demodicosis) — Studies published in Parasites & Vectors have shown fluralaner to be effective against Demodex canis mites, often resolving cases within 56-84 days with a single or two-dose protocol
• Sarcoptic mange (sarcoptic scabies) — FDA-approved indication added after initial launch; Bravecto treats and controls Sarcoptes scabiei for 12 weeks
• Ear mite treatment — emerging veterinary dermatology use, though your vet may prefer topical alternatives

Any off-label use should be explicitly directed and monitored by your veterinarian. Dosages for mange treatment may differ from standard flea/tick prevention protocols.

How Does Bravecto Work? Mechanism of Action Explained

Important distinction: Bravecto is a systemic medication — it circulates in your dog's bloodstream and kills parasites when they bite. It is not a repellent. Your dog may still have fleas or ticks attach briefly before they die, which matters if you live in an area with high tick-borne disease prevalence where rapid kill time is critical.

Bravecto Chews Dosage by Weight: What Your Vet Will Prescribe

Bravecto chews come in five weight-specific formulations. Your veterinarian will select the appropriate chewable based on your dog's current weight at the time of prescribing.

Target dosage: The minimum effective dose is 25 mg/kg (11.4 mg/lb) of fluralaner, administered orally once every 12 weeks. For dogs over 123 lbs, your veterinarian will prescribe the appropriate combination of chewables to reach the target dose.

Administration Instructions

• Give with food. Bravecto chews should be administered at or around the time of feeding. Bioavailability of fluralaner increases significantly when given with a meal — the FDA label specifically notes enhanced absorption with food, which is critical for achieving therapeutic blood levels.
• Frequency: One chew every 12 weeks (approximately every 3 months) for flea and tick prevention. Some veterinarians recommend every 8 weeks in high-tick-pressure areas or for dogs with tick-borne disease history.
• Observe after dosing: Watch your dog for 30-60 minutes after administration to ensure they don't vomit the chew. If vomiting occurs within 2 hours of dosing, contact your vet — a replacement dose may be needed.
• Do not break or split chews — the medication distribution within the chew matrix is calibrated for whole-tablet delivery.

Bravecto Side Effects: What the Clinical Data Shows

Understanding the real frequency and severity of side effects helps you make an informed decision with your veterinarian. The following data comes from pre-approval field studies and post-market surveillance reported to the FDA.

The Seizure Question: What We Know

In 2018, the FDA issued an alert about neurological adverse events associated with isoxazoline-class drugs, including fluralaner. Reports of seizures, muscle tremors, and ataxia prompted the FDA to require updated labeling across the entire drug class. It's important to understand the context:

• The reported incidence of neurological events is extremely low relative to millions of doses administered — post-market surveillance data suggests a rate well under 0.1%.
• Dogs with pre-existing seizure disorders or epilepsy appear to be at higher risk. The FDA label advises using Bravecto with caution in dogs with a history of seizures.
• Most reported neurological events have been self-limiting, though some dogs required veterinary intervention.
• The mechanism is thought to involve GABA receptor cross-reactivity — since fluralaner targets GABA-gated chloride channels in parasites, there is theoretical potential for interaction with mammalian GABA receptors at high concentrations, though canine GABA receptors have much lower affinity for isoxazolines.

Contraindications: Dogs Who Should NOT Receive Bravecto

Your veterinarian will screen for these contraindications before prescribing:

• Puppies under 6 months of age — safety has not been established in puppies younger than 6 months
• Dogs weighing less than 4.4 lbs (2 kg) — no approved dosage formulation exists for this weight class
• Dogs with known hypersensitivity to fluralaner or any ingredient in the chew formulation
• Dogs with a history of seizures or epilepsy — use with caution and only under close veterinary monitoring; your vet may recommend an alternative drug class

Pregnancy, Lactation, and Breeding Dogs

Bravecto chews have been evaluated for safety in breeding, pregnant, and lactating dogs. Studies showed no treatment-related effects on reproductive performance, pregnancy outcomes, or puppy development. However, as with any medication, your veterinarian should weigh the benefits against risks for breeding females on a case-by-case basis.

Drug Interactions to Discuss with Your Veterinarian

Always disclose every medication, supplement, and over-the-counter product your dog is receiving to your veterinarian. This includes flea/tick products you may have purchased without a prescription, as combining parasiticide classes can lead to toxicity.

How Long Does My Dog Need to Be on Bravecto?

This depends entirely on your dog's risk profile and your veterinarian's recommendation:

• Year-round prevention (most US dogs): The Companion Animal Parasite Council (CAPC) and most veterinary organizations recommend year-round flea and tick prevention for dogs in most of the United States. This means administering Bravecto four times per year (every 12 weeks).
• Seasonal prevention (limited regions): In areas with defined tick seasons — parts of the northern US and Canada — your vet may recommend starting 1 month before tick season and continuing through 1 month after the first hard frost. Even then, fleas can persist indoors year-round.
• Mange treatment protocols: For demodectic or sarcoptic mange, your vet may prescribe a short course (1-3 doses spaced 4-12 weeks apart) with follow-up skin scrapings to confirm resolution. Treatment duration depends on the severity and type of mange.

There is no lifetime commitment implied by starting Bravecto — you can switch preventives at any time with your veterinarian's guidance, typically timing the switch for when the current dose's protection window expires.

Monitoring Requirements

No routine blood work is specifically required for Bravecto monitoring in healthy dogs. However, your veterinarian may recommend baseline bloodwork as part of your dog's overall wellness plan, especially for senior dogs or those with pre-existing conditions.

Cost Breakdown and Generic Availability

Bravecto is a brand-name medication manufactured by Merck Animal Health. As of 2026, there is no FDA-approved generic equivalent of fluralaner available in the United States for dogs. The medication is available only through veterinary clinics and licensed online pet pharmacies (with a valid prescription).

Cost context: At roughly $50-$75 per dose, Bravecto's annual cost of $200-$300 for a medium-to-large dog is competitive with monthly preventives. Twelve NexGard doses (afoxolaner) typically cost $250-$360 annually, while 12 Simparica Trio doses can run $300-$420. The 12-week dosing interval means fewer administration events, which many owners find worth the per-dose price.

Tip: Many veterinary clinics offer multi-dose discounts when you purchase 2-4 chews at once. Some also include the Bravecto prescription as part of a wellness plan package. Ask your clinic about bundle pricing.

What to Do If You Miss a Dose or Suspect an Overdose

Missed Dose Protocol

If you forget to give your dog's Bravecto chew on schedule:

1. Administer the missed dose immediately with food, as soon as you remember.
2. Reset the 12-week clock from the date you actually gave the chew (not the date it was due).
3. Do NOT double up. Never give two chews at once to "catch up" — this increases the risk of side effects without improving efficacy.
4. Check for parasites. If the gap between doses exceeded 14-16 weeks, your dog may have been unprotected. Inspect for fleas and ticks, and discuss with your vet whether tick-borne disease testing is warranted.

Overdose Response

If your dog accidentally ingests more than the prescribed dose (e.g., got into the medicine cabinet, or you accidentally gave the wrong weight-class chew):

1. Note the exact amount ingested and the time of ingestion.
2. Call your veterinarian or emergency vet clinic immediately.
3. Call ASPCA Animal Poison Control: (888) 426-4435 (available 24/7, consultation fee of approximately $95 applies).
4. Monitor for neurological signs: tremors, seizures, ataxia, excessive drooling, vomiting.
5. Do not induce vomiting unless instructed by a veterinary professional.

In safety studies, fluralaner was administered at up to 5 times the recommended dose (125 mg/kg) to healthy dogs. At these supratherapeutic doses, some dogs experienced tremors and seizures, which were transient and resolved with supportive care. However, individual sensitivity varies, and any overdose warrants professional veterinary assessment.

Are There Alternatives to Bravecto Chews?

Several FDA-approved flea and tick preventives exist across different drug classes and administration routes. Your veterinarian will consider your dog's health history, lifestyle, and your preferences when recommending an alternative.

When your vet might recommend switching away from Bravecto:

• Your dog has a seizure history → a non-isoxazoline option like Seresto or Frontline Plus may be preferred
• Your dog consistently vomits oral medications → topical Bravecto or a spot-on alternative
• You want heartworm protection in a single product → Simparica Trio or a separate heartworm preventive alongside Bravecto
• Your dog is under 6 months old → NexGard (approved from 8 weeks) or Frontline Plus (approved from 8 weeks)

Bottom line: Bravecto chews for dogs offer a convenient, long-lasting flea and tick prevention option backed by over a decade of clinical use and millions of administered doses. The 12-week dosing interval reduces missed-dose risk compared to monthly products, and the overall safety profile is favorable for the vast majority of dogs. However, the isoxazoline class carries a documented (if rare) neurological risk that should be discussed with your veterinarian — especially for dogs with seizure histories. Always consult your veterinarian to determine whether Bravecto is the right preventive for your individual dog's health profile and lifestyle.